ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Focal Segmental Glomerulosclerosis Recurrence in Renal Transplant Recipients Treated with Belatacept.

    W. Kitchens, A. Farris, S. Pastan, T. Pearson, C. Larsen, A. Adams.

    Emory Transplant Center, Atlanta, GA

    Introduction: Focal segmental glomerulosclerosis (FSGS) is a cause of end-stage renal failure that frequently recurs following renal transplant, often leading to allograft loss. A recently…
  • 2017 American Transplant Congress

    Steroid Withdrawal Using Everolimus in Maintenance Kidney Transplant Recipients with Post-Transplant Diabetes Mellitus.

    K. Nanmoku, A. Kurosawa, T. Kubo, T. Shinzato, T. Shimizu, T. Kimura, T. Yagisawa.

    Surgical Branch, Institute of Kidney Diseases, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan

    Background: Although steroid withdrawal from conventional immunosuppressive therapy has been attempted to ameliorate various complications, especially diabetes mellitus (DM), in kidney transplant recipients, a steroid-sparing…
  • 2017 American Transplant Congress

    A Prospective Observational Study to Evaluate Use of a Panel of Reactive T Cell (PRT) Assay as a Pre-Transplant Marker of Rejection in Kidney Transplant Recipients.

    D. Brennan,1 L. Kayler,2 D. Wojciechowski,3 A. Limaye,4 A. Gaber,5 I. Durrant.6

    1Washington University, St. Louis, MO; 2Erie County Medical Center, Buffalo, NY; 3Massachusetts General Hospital, Boston, MA; 4Washington University, Seattle, WA; 5Houston Methodist, Houston, TX; 6Oxford Immunotec, Oxfordshire, United Kingdom

    Background:To assess risk of T cell mediated acute rejection a recently developed assay uses a panel of reactive T cell lines (PRT) to measure recipient…
  • 2017 American Transplant Congress

    Change in QTC Interval After Kidney Transplant.

    E. Lai, V. Acharya, D. Nguyen, E. Graviss, W. Suki.

    Houston Methodist Hospital, Houston, TX

    Cardiovascular (CV) disease is the leading cause of mortality in ESRD patients. A prolonged QTc interval on EKG is a predictor of adverse CV outcomes.…
  • 2017 American Transplant Congress

    Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg Can Be Performed Safely.

    K. Hata,1 M. Okumi,1 K. Ishizuka,2 K. Unagami,3 T. Hirai,1 T. Shimizu,1 K. Omoto,1 H. Ishida,1 M. Hattori,2 K. Tanabe.1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan; 2Pediatric Nephrology, Tokyo Women's Medical University, Tokyo, Japan; 3Nephrology, Tokyo Women's Medical University, Tokyo, Japan

    INTRODUCTION AND OBJECTIVES: Pediatric kidney transplantation is associated with various surgical complications due to the complexity of technique and often fragile condition of end-stage renal…
  • 2017 American Transplant Congress

    Sexual Dysfunction Among Living Kidney Donors.

    S. Halpern,1 A. Thomas,1 C. Holscher,1 A. Massie,1 M. Henderson,1 S. Anjum,1 J. Locke,2 D. Segev.1

    1JHU, Baltimore, MD; 2UAB, Birmingham, AL

    Ensuring high post-donation quality of life among living kidney donors (LKDs) is a critical component of making living donation worthwhile for both recipients and donors.…
  • 2017 American Transplant Congress

    Predictive Value of Renal Poly (ADP-Ribose) Polymerase (PARP) Expression Both in Inflammation and Interstitial Fibrosis Processes in Recipients with Antibody-Mediated Rejection.

    B. Ozdemir,1 F. Ozdemir,2 E. Baskin,2 M. Haberal.3

    1Pathology, Baskent University, Ankara, Turkey; 2Nephrology, Baskent University, Ankara, Turkey; 3Transplant Surgery, Baskent University, Ankara, Turkey

    The activation of PARP is well considered to play an augmenting role in inflammation. However, its role in the development of fibrosis is not well…
  • 2017 American Transplant Congress

    Impact of Non-Adherence in a Cohort of Kidney Transplant Recipients.

    M. Merino-López,1 C. Flores-Gama.2

    1National Autonomous University of Mexico, Mexico, Mexico; 2Nephrology, National Institute of Cardiology, Mexico, Mexico

    Background: The understanding of the main causes of allograft losts and related factors is a critical in the sucess of kidney transplantation programs.Objective: The aim…
  • 2017 American Transplant Congress

    Cost-Effectiveness of Renal Machine Perfusion Use After Long Cold Ischemia Time.

    A. Matos,1 D. Malheiro,3 S. Morgado,1 L. Requi[acirc]o-Moura,1 M. Souza-Durão,1,2 E. Tonato,1 M. Nogueira,1 M. Borrelli,1 A. Pacheco-Silva.1,2

    1Renal Transplant, Hospital Israelita Albert Einstein, São Paulo, Brazil; 2Nephrology, Universidade Federal de São Paulo, São Paulo, Brazil; 3Health Economics Department, Hospital Israelita Albert Einstein, São Paulo, Brazil

    High cold ischemia time (CIT) and inadequate care of donors in Brazil lead to a high incidence of delayed graft function (DGF), 60%-70%, and as…
  • 2017 American Transplant Congress

    mTOR Inhibition Diminishes Peripheral Blood CD8+CD28–CD38hi Effector/Memory T Cells and Facilitates Resolution of Belatacept-Refractory Kidney Rejection.

    C. Castro-Rojas,1 A. Godarova,1 A. Leino,2 R. Alloway,2 M. Jordan,3 E. Woodle,2 D. Hildeman.1

    1Division of Immunobiology, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH; 2Division of Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH; 3Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Research Foundation, Cincinnati, OH

    Belatacept, a CD28-CD80/86 blocker, was approved by the FDA to provide immunosuppression without nephrotoxicity or cardiovascular and metabolic adverse effects. As part of our multi-center…
  • « Previous Page
  • 1
  • …
  • 376
  • 377
  • 378
  • 379
  • 380
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences